Details for New Drug Application (NDA): 020151
✉ Email this page to a colleague
The generic ingredient in EFFEXOR is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.
Summary for 020151
Tradename: | EFFEXOR |
Applicant: | Wyeth Pharms Inc |
Ingredient: | venlafaxine hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020151
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 28, 1993 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 28, 1993 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 28, 1993 | TE: | RLD: | Yes |
Expired US Patents for NDA 020151
Complete Access Available with Subscription